15 companies

Inventiva

Market Cap: €806.9m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.

IVA

€3.33

7D

3.3%

1Y

20.9%

Valneva

Market Cap: €438.1m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

VLA

€2.29

7D

1.3%

1Y

-6.1%

Cellectis

Market Cap: €204.9m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

ALCLS

€2.73

7D

5.6%

1Y

100.9%

Innate Pharma

Market Cap: €160.4m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

IPH

€1.65

7D

1.9%

1Y

9.3%

Sensorion

Market Cap: €132.8m

A biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France.

ALSEN

€0.25

7D

5.7%

1Y

-29.0%

OSE Immunotherapeutics

Market Cap: €84.2m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

OSE

€3.43

7D

9.9%

1Y

-30.4%

Adocia

Market Cap: €82.8m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

ADOC

€3.97

7D

-4.1%

1Y

3.8%

ABIONYX Pharma

Market Cap: €72.0m

A biotech company, discovers and develops therapies for the treatment of renal, metabolic, and ophthalmic diseases in France and the United States.

ABNX

€1.93

7D

-5.7%

1Y

61.2%

AB Science

Market Cap: €60.8m

A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.

AB

€0.76

7D

-14.7%

1Y

-47.1%

MaaT Pharma

Market Cap: €51.6m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

MAAT

€2.70

7D

13.4%

1Y

-43.8%

THX Pharma Société Anonyme

Market Cap: €50.2m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

ALTHX

€3.52

7D

6.0%

1Y

181.6%

Nicox

Market Cap: €34.7m

Operates as an ophthalmology company in France and internationally.

ALCOX

€0.39

7D

3.2%

1Y

74.3%

Advicenne

Market Cap: €32.2m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

ALDVI

€1.62

7D

29.8%

1Y

17.5%

GenSight Biologics

Market Cap: €19.5m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

SIGHT

€0.082

7D

1.7%

1Y

-36.7%

Valbiotis

Market Cap: €19.4m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia.

ALVAL

€0.81

7D

0.1%

1Y

-3.5%